top of page
“Cost-Effectiveness Analysis for Priority Setting,” Disease Control Priorities in Developing Countries, Second Edition, with Julia Fox-Rushby, New York: Oxford University Press and The World Bank, 2006.
Earmarking Could Be Beneficial: Cost-effectiveness is Not the Only Criterion. Round Table Discussion on the Economics of Immunization, Bulletin of the World Health Organization, 82(9), 2004: 706-707.
bottom of page